CCND2 and prostate carcinoma: Moreover, SFN was able to decrease the expression of DNMT1 and DNMT3 in LnCap prostate cancer cells, as well as to reduce methylation in Cyclin D2 promoter, thus inducing Cyclin D2 gene expression in those cells.